Aberrant promoter methylation in sputum and serum for lung cancer detection

Steven A. Belinsky; Kevin K. Divine; Manel Esteller; Stephen B. Baylin; James G. Herman; William A. Palmisano

Related publications

Article1999

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Manel Esteller, Montse Sánchez‐Céspedes, Rafael Rosell, David Sidransky, Stephen B. Baylin, James G. Herman

Article2015

Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts

Miguel Vizoso, Marta Puig, F. Javier Carmona, María Maqueda, Adriana Velásquez, Antonio Gómez, Anna Labernadie, Roberto Lugo, Marta Gabasa, Luis G. Rigat-Brugarolas, Xavier Trepat, José Ramírez, Sebastián Morán, Enrique Vidal, Noemı́ Reguart, Alexandre Perera-Lluna, Manel Esteller, Jordi Alcaraz

Article2017

Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer

João Carvalho, Inês Graça, Antonio Gómez, Jorge Oliveira, Rui Henrique, Manel Esteller, Cármen Jerónimo

Article2011

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients

Carmen Balañá, Cristina Carrato, José Luis Ramírez, Andrés F. Cardona, Mireia Berdiel‐Acer, José Javier Sánchez, Miquel Tarón, C. Hostalot, Eva Musulen, Aurelio Ariza, Rafael Rosell

Article2003

Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.

William A. Palmisano, Kevin Patrick Crume, Marcie J. Grimes, Sally A Winters, Minoru Toyota, Manel Esteller, Nancy E. Joste, Stephen B. Baylin, Steven A. Belinsky